ACTA ENDOCRINOLOGICA-BUCHAREST, vol.7, no.4, pp.545-549, 2011 (SCI-Expanded)
The conventional treatment of hypoparathyroidism consists of vitamin ID analogues in combination with oral calcium supplementation. This treatment modalities induce chronic hypercalciuria which leads to nephrocalcinosis, nephrolithiasis and renal insufficiency. Here we report the case of a 32-year-old woman who developed hypocalcemia and hypercalciuria under treatment with high doses of vitamin D analogs and oral calcium. She had cerebral calcification, nephrocalcinosis under this treatment. Stable calcium levels were achieved with synthetic human parathyroid hormone treatment that was given in alternate days. PTH appears to be an alternative and effective treatment in hypoparathyroidism.